Study objectives: The single-breath diffusing capacity of the lung (DLCO) is a commonly performed pulmonary function test. The current American Thoracic Society (ATS) recommendations for reproducibility of DLCO measurements suggest that two measurements for the DLCO agree within 10% or 3 mL/min/mm Hg of the average value. The European Respiratory Society (ERS) recommends that two measurements should agree within 10%. The objectives of the present study were to examine whether the current reproducibility criteria were met in a general pulmonary function laboratory and to determine whether alternative criteria might be appropriate. Design: Cross-sectional study. Key words: diffusing capacity; measurement variability; pulmonary function testing; reproducibility; transfer factor Abbreviations: ATS ϭ American Thoracic Society; CI ϭ confidence interval; CV ϭ coefficient of variation; Dlco ϭ single-breath diffusing capacity of the lung for carbon monoxide; ERS ϭ European Respiratory Society; FRC ϭ functional residual capacity; PFT ϭ pulmonary function test; RV ϭ residual volume; STPD ϭ standard temperature and pressure, dry; SVC ϭ slow vital capacity; TLC ϭ total lung capacity; Vi ϭ inspired volume S ingle-breath diffusing capacity of the lung for carbon monoxide (Dlco) is the most common method for measuring diffusing capacity of the lung.
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In 1987, the American Thoracic Society (ATS) published a consensus statement on the single-breath technique for measuring Dlco and recommended that two acceptable measurements should be within 10% or 3 mL CO (standard temperature and pressure, dry [STPD] )/min/mm Hg of the average Dlco. 1 The consensus statement was motivated by the need to standardize the measurement of Dlco and decrease interlaboratory and intralaboratory variability. In 1993, the European Respiratory Society (ERS) published a similar report for standardization of measuring Dlco and recommended that two measurements should agree within 10%. 2 In contrast to the ATS report, the ERS statement did not include absolute difference as part of the acceptability criteria. The consensus statement required that the "average of two determinations which agree to within 10%" should be reported. The ERS statement is ambiguous because it is not clear whether the two Dlco measurements should be within 10% of the mean or 10% of the smallest or the largest value. To address new technological developments in the equipment used to measure Dlco and clarify the differences between the ATS and ERS statements, the ATS published an updated report in 1995. The revised statement maintained the standards for Dlco reproducibility that were originally professed in the 1987 ATS report. 3 Since that revision, there have been no studies testing the utility of the published criteria for Dlco variability in a general pulmonary function laboratory. Moreover, although it is generally expected that underlying lung disease can increase measurement variability, the effects of obstructive and restrictive ventilatory defects on variability of Dlco measurement have not been thoroughly investigated. Therefore, the objectives of the present study were as follows: (1) to determine the percentage of patients that meet the current recommendations for Dlco variability in a large urban university clinical laboratory, (2) to assess the feasibility of alternative reproducibility criteria, and (3) to explore the effect of varying degrees of obstructive and restrictive ventilatory impairment on Dlco measurement variability.
Materials and Methods
We conducted a retrospective review of pulmonary function test (PFT) results for patients referred to the pulmonary function laboratory over a consecutive 3-year period. Approval for use of the pulmonary function data were obtained from the institutional review board on human research. Patient confidentiality was maintained by removing all identifying information from the clinical data. PFT records were reviewed to select patients who underwent spirometry and had Dlco measured during the same visit. To eliminate inclusion of multiple measurements, only the first PFT for each patient was selected for the present study. Standard techniques for PFTs, in general accordance with the current guidelines, were used. 4 -6 Equipment was manufactured by W.E. Collins (Braintree, MA) or was custom designed for the laboratory. Spirometry was performed to obtain the FEV 1 and the FVC. Lung volume measurements were available on a subset of the patient sample. Functional residual capacity (FRC) in this subset was measured with the multiple-breath helium dilution method. Slow vital capacity (SVC) and expiratory reserve volume were measured in triplicate at the end of each multiple-breath procedure. Residual volume (RV) was calculated by subtracting the average expiratory reserve volume from FRC. Total lung capacity (TLC) was determined by adding the largest SVC to the calculated RV. Alveolar volume and Dlco were measured using the single-breath method in accordance with ATS guidelines with the following exceptions. 3 First, the algorithm used to calculate breath-hold time measured the time from the onset of inspiration to the beginning of sample collection. Second, alveolar volume was not corrected for anatomic dead space. Patients attempted a maximum of five maneuvers to obtain two acceptable and reproducible Dlco measurements. An acceptable maneuver was defined as an inspiratory breath of at least 90% of FVC, breath-hold time of 9 to 11 s, and a rapid inspiration, as defined in the ATS statement. 3 Reproducible measurements were defined as any two measurements whose difference is Յ 10% of the average value. If a patient could not meet these criteria, the two acceptable measurements were then recorded. All patients, however, had a Dlco reported as long as one acceptable maneuver was performed. Predicted values for spirometry, helium lung volumes, and Dlco were based on prediction equations derived from the literature. 4, 7 Patients with lung volume data were characterized based on the type of ventilatory impairment. The following criteria were used: restrictive ventilatory impairment (TLC Յ 80% and FEV 1 / FVC Ն 0.80), obstructive ventilatory impairment (TLC Ͼ 80% and FEV 1 /FVC Յ 0.80), mixed obstructive and restrictive ventilatory impairment (TLC Յ 80% and FEV 1 /FVC Ͻ 0.80), or no ventilatory impairment (TLC Ͼ 80% and FEV 1 /FVC Ն 0.80). Three measures of Dlco reproducibility were examined: (1) absolute difference, (2) percentage difference, and (3) the coefficient of variation (CV). Absolute difference between two repeated measures was defined as follows:
Percentage difference was calculated as a ratio of the absolute difference to the average of the two repeated measures:
CV was determined as follows:
The number and percentage of patients meeting different reproducibility criteria were determined. Patients were grouped according to the type of ventilatory impairment (obstructive, restrictive, and mixed) to assess the impact of abnormal lung function on Dlco variability. Analysis was performed using statistical software (SAS 8.0; SAS Institute; Cary, NC).
Results

Demographic and Pulmonary Function Characteristics
A total of 6,193 unique PFT records were selected for the current study with availability of spirometry and Dlco measurement during the same visit. Patient characteristics and pulmonary function data for the study sample are summarized in Table 1 
Reproducibility of DLCO
The distribution of actual number of Dlco trials performed per individual for the study sample was as follows: 39.3% (two tests), 22.5% (three tests), 10.5% (four tests), 17.5% (five tests), and 10.1% (missing data on number of trials). Of the 6,193 patients, 98.3% patients met the current ATS criteria and had two Dlco values that were within 10% or 3 mL CO (STPD)/min/mm Hg of the average value. Figure 1 shows the percentage of patients that met other candidate criteria for Dlco reproducibility. Above an absolute difference of 2 mL CO (STPD)/min/mm Hg between two measurements, the proportion of patients that met alternate criteria remained relatively unchanged despite varying degrees of percentage difference requirement. At or below an absolute difference of 2 mL CO (STPD)/min/mm Hg between two measurements, the number of patients that met criteria decreased as the percentage difference criteria was made more stringent (Fig 1) . Table 2 summarizes the measures of Dlco reproducibility for the entire study sample. Subgroup analyses for patients without lung volume measurements showed no significant differences in the measures of Dlco reproducibility compared to the full study sample. In patients with lung volume measurements, the measures of Dlco reproducibility were also examined across categories of ventilatory impairment (Table 3) . Patients with either an obstructive, restrictive, or mixed defect had more variability in measurement as reflected by the mean percentage difference and the mean CV compared to those without any ventilatory impairment. However, the absolute difference between two tests remained relatively stable across patients with and without ventilatory impairment. Measurement variability was also examined across different levels of inspired volume (Vi). As the ratio of Vi to vital capacity (largest of FVC or SVC) increased, variability in Dlco measurement decreased (Table 4) .
To examine other determinants of Dlco reproducibility, we examined the associations between several patient factors and each index of Dlco reproducibility. As the degree of airflow obstruction increased, as assessed by the FEV 1 percentage of predicted, there was an increase in the percentage difference (Fig 2, top) and CV (data not shown). However, there was relatively minimal change in the absolute difference between two Dlco measurements with decreasing FEV 1 percentage of predicted (Fig 2, bottom) . Measurement variability was also inversely related to the baseline average Dlco (Fig 3, top) . Although the absolute difference between two Dlco measurements increased with increasing Dlco (percentage of predicted), the change was relatively small and insignificant (Fig 3, bottom) .
We also examined whether other patient factors, including gender and race, would be predictive of variability in Dlco measurement. Men, on average, had a higher mean Dlco (20.1 mL/min/mm Hg vs 16.4 mL/min/mm Hg, p Ͻ 0.0001) and a higher mean absolute difference (0.93 mL CO [STPD]/min/ mm Hg vs 0.88 mL CO [STPD]/min/mm Hg, p Ͻ 0.03) compared to women. Thus, the mean CV for men compared to women was lower (3.8% vs 4.3%, p Ͻ 0.0001) as was the mean percentage difference (5.3% vs 6.2%, p Ͻ 0.001). Multivariable linear regression models of each reproducibility index (absolute difference, percentage difference, and CV) revealed no associations with gender after adjusting for the average Dlco. Bivariate analyses also demonstrated that African Americans had a lower average Dlco (16.8 mL/min/mm Hg vs 19.0 mL/ min/mm Hg, p Ͻ 0.0001) than whites. The mean CV and the mean absolute difference between the two Dlco measurements in African Americans was 4.5% and 0.94 mL CO (STPD)/min/mm Hg, respectively. In contrast, the mean CV and mean absolute difference in whites was 3.8% and 0.88 (STPD)/min/mm Hg, respectively. Since African Americans in this group were also found to have a lower FEV 1 percentage of predicted and a higher proportion of women compared to whites (62.0% vs 47.7%, p Ͻ 0.0001), multivariable linear regression models were used to examine the independent relationship between race and Dlco reproducibility. After adjusting for gen- 
Discussion
The present study examined the utility of the current recommendations on reproducibility limits for the measurement of single-breath Dlco. Using a consecutive sample of patients referred to a general pulmonary function laboratory, 98.3% patients referred for clinical testing met the current ATS reproducibility criteria for repeat Dlco measurement. The use of alternative criteria that are more stringent did not significantly alter the number of patients that could fulfill these criteria under routine testing in accordance with the current standards. The results of this study also indicate that patient factors, such as gender and race, are not significantly associated with measurement variability for the single-breath method. In contrast, the presence of an obstructive or restrictive ventilatory defect was associated with an increase in measurement variability. Other factors associated with increased measurement variability included the following: (1) a ratio of Vi to vital capacity Ͻ 90%, (2) a low FEV 1 percentage of predicted, and (3) a low Dlco.
The current guideline for reproducibility in the ATS standards is to perform at least two maneuvers that agree within 10% or 3 mL/min/mm Hg of the average value. 3 Thus, two Dlco maneuvers could differ by as much as 20% or 6 mL/min/mm Hg and still be considered reproducible. It is the policy in our laboratory to perform testing until two maneuvers are obtained which are within 10% of the average up to a maximum of five maneuvers depending on the cooperation of the patient. In a patient population referred for clinical testing, we could successfully fulfill the current ATS reproducibility criteria in virtually all cases where two acceptable maneuvers could be obtained. Moreover, 95.9% of the patient sample had two Dlco measurements within 5% and 2.5 mL/min/mm Hg of each other. These results are consistent with data from a Norwegian population-based study that showed that 98% of the volunteers from the community could meet the current ATS criteria for Dlco reproducibility. 8 Thus, the current standards for Dlco reproducibility may be too liberal to meaningfully enforce good performance.
The results of the current study also reveal that the CV and percentage difference were largest in patients with abnormal lung function. Because the mean Dlco is used in the calculation of the CV and the percentage difference, the finding of higher measurement variability in patients with lung disease may simply reflect a lower mean Dlco. However, the possibility that there is also inherently greater variation due to the underlying lung disease cannot be completely excluded. The implication of these findings is that the use of percentage reproducibility alone as a criterion for ending a test session would require that more maneuvers be performed in individuals with lower Dlco. The ATS standards address this issue by allowing a session to be considered reproducible if two acceptable values are within 3 mL/min/mm Hg of the average value. This criterion could be met in Ͼ 98% of the sample, regardless of the percentage difference, and thus is also very liberal.
Based on the present investigation, it would be reasonable to consider alternative criteria for Dlco reproducibility. A variety of alternatively reproducibility criteria and the percentage of patients meeting these criteria are presented in Figure 1 . Ninety to 95% of the patients should be able to perform a reproducible Dlco measurement if they can perform two acceptable maneuvers. Any reproducibility criteria that take into account the percentage difference will tend to show better performance in patients with larger baseline Dlco values. Thus, we would propose that a reasonable criterion for Dlco reproducibility would be to consider an absolute difference of 2 to 2.5 mL CO (STPD)/min/mm Hg between two measurements, which were met in 91.5% and 95.8% of the patients, respectively.
There are several limitations in the current study. First, it should be noted that the technique for performing the Dlco in our laboratory varies slightly from the ATS guidelines. We have done this to maintain stability in our reported measurements as the standards change over time. While this may have a slight effect on the reported Dlco values, it is not likely that it should affect reproducibility within individuals. 9 Second, pulmonary function testing in our laboratory is performed on two different types of testing systems, one a commercial system (W.E. Collins) with customized software, and the other a locally fabricated apparatus with an automated valve. It is possible that the intrasubject variability could differ with other types of equipment, although this is unlikely since most automated systems perform in a similar fashion to those in use in our laboratory. Restricting the analyses to tests performed on one system vs another revealed statistically small differences in the measures of Dlco reproducibility that were not clinically meaningful. For example, the average absolute difference for tests performed on the commercial system was 0.81 (95% CI, 0.76 to 0.85), whereas the average absolute difference for tests performed on the locally fabricated apparatus was 0.96 (95% CI, 0.93 to 0.99).
Although these values were statistically different, inferences regarding the use of absolute difference instead of the percent difference between repeat measurements did not change when the analysis was restricted to a specific system. Despite these limitations, the current study has several strengths. Because we utilized pulmonary function data from a general clinical laboratory, the study sample included a broad range of patients that are typical for a metropolitan academic medical center. Furthermore, the testing was performed by at least seven different technicians with a wide range of experience. Thus, we suspect that our results would show larger variability then might be expected in other more controlled settings such as a research study or surveys of a general population.
In summary, reproducibility in the measurement of Dlco is generally much better than the current recommended standards. Based on the results of the current study, we suggest that future standards should consider setting a more stringent criteria based on an absolute difference in test results rather than a percentage difference.
